In vitro activation of pro-tumorigenic pathways and an increase in cell proliferation following tumor cell exposure to rPD-1 corroborate our in-vivo findings showing blockade of PD-1/PD-L1 interaction resulted in reduced Ki67 staining in metastases. Here, MKI67 is linked to neoplasm.